TNF-based isolated limb perfusion: a decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas
- PMID: 15217218
- DOI: 10.1007/1-4020-7856-0_4
TNF-based isolated limb perfusion: a decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas
Similar articles
-
Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.Ann Surg Oncol. 2000 Mar;7(2):155-9. doi: 10.1007/s10434-000-0155-1. Ann Surg Oncol. 2000. PMID: 10761796
-
Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.Ann Surg. 1996 Dec;224(6):756-64; discussion 764-5. doi: 10.1097/00000658-199612000-00011. Ann Surg. 1996. PMID: 8968230 Free PMC article. Clinical Trial.
-
Hyperthermic isolated limb perfusion with tumour necrosis factor-alpha and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile?Arch Orthop Trauma Surg. 1998;118(1-2):70-4. doi: 10.1007/s004020050314. Arch Orthop Trauma Surg. 1998. PMID: 9833110
-
Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcoma.Cancer. 2016 Sep 1;122(17):2624-32. doi: 10.1002/cncr.29991. Epub 2016 May 19. Cancer. 2016. PMID: 27197621 Review.
-
Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities.Recent Results Cancer Res. 2009;179:257-70. doi: 10.1007/978-3-540-77960-5_16. Recent Results Cancer Res. 2009. PMID: 19230545 Review.
Cited by
-
Soft tissue sarcoma clinical practice guidelines in oncology.J Natl Compr Canc Netw. 2005 Mar;3(2):158-94. J Natl Compr Canc Netw. 2005. PMID: 19817028 Free PMC article. No abstract available.
-
Integrin targeted delivery of chemotherapeutics.Theranostics. 2011 Feb 17;1:189-200. doi: 10.7150/thno/v01p0189. Theranostics. 2011. PMID: 21547159 Free PMC article.
-
Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.Biochem Insights. 2008 Jul 22;2008:15-21. Biochem Insights. 2008. PMID: 24115841 Free PMC article.
-
Trial watch: Immunostimulatory cytokines in cancer therapy.Oncoimmunology. 2014 Jun 3;3:e29030. doi: 10.4161/onci.29030. eCollection 2014. Oncoimmunology. 2014. PMID: 25083328 Free PMC article.
-
Tumor Necrosis Factor: What Is in a Name?Cancers (Basel). 2022 Oct 27;14(21):5270. doi: 10.3390/cancers14215270. Cancers (Basel). 2022. PMID: 36358688 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical